Clinical Research in Cardiology

, Volume 95, Issue 6, pp 344–348 | Cite as

Coronary vasospasm–induced acute diastolic dysfunction in a patient with Raynaud’s phenomenon

  • Carsten Tschöpe
  • Dirk Westermann
  • Paul Steendijk
  • Mario Kasner
  • Martin Rudwaleit
  • Peter L. Schwimmbeck
  • Wolfgang C. Poller
  • Heinz-Peter Schultheiss
CASE REPORT

Summary

We present the case of a patient with severe dyspnea and Raynaud’s phenomenon. We could clarify, using invasive techniques including left ventricular conductance catheterization and coronary ergonovine provocation, that isolated diastolic dysfunction induced by coronary vasospasm were responsible for the symptoms. Systolic function was not affected. Short–term infusions with the prostacyclin analogue iloprost, known to act as a disease–modifying agent in patients suffering from Raynaud’s phenomenon, led to an improvement of cardiac function. Thus, episodes of dyspnea in patients with Raynaud’s phenomenon might be also interpretated as a coronary ischemia equivalent, which may belong to a visceral form of Raynaud’s phenomenon and which are sensitive to iloprost infusions.

Key words

Diastolic dysfunction coronary vasospasm pressure volume loops Raynaud’s phenomenon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kass DA, Midei M, Graves W, Brinker JA, Maughan WL (1988) Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure– volume relationships in man. Cathet Cardiovasc Diagn 15:192–202PubMedGoogle Scholar
  2. 2.
    Mittag M, Beckheinrich P, Haustein UF (2001) Systemic sclerosis–related Raynaud’s phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels. Acta Derm Venereol 81:294–297PubMedCrossRefGoogle Scholar
  3. 3.
    Scorza R, Caronni M, Mascagni B, Berruti V, Bazzi S, Micallef E, Arpaia G, Sardina M, Origgi L, Vanoli M (2001) Effects of long–term cyclic iloprost therapy in systemic sclerosis with Raynaud’s phenomenon. A randomized, controlled study. Clin Exp Rheumatol 19:503–508PubMedGoogle Scholar
  4. 4.
    Tzivoni D (1993) Effect of transient ischemia on left ventricular function and prognosis. Eur Heart J 14 (Suppl A):2–7PubMedGoogle Scholar
  5. 5.
    Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548PubMedCrossRefGoogle Scholar
  6. 6.
    Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, Schultheiss HP (2005) High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111:879–986PubMedCrossRefGoogle Scholar
  7. 7.
    Maeder M, Ammann P, Angehrn W, Rickli H (2003) A case of coronary vasospasm treated with stent placement. Z Kardiol 92:182–187PubMedCrossRefGoogle Scholar
  8. 8.
    Generini S, Del Rosso A, Pignone A, Matucci–Cerinic M (2003) Current treatment options in Raynaud’s phenomenon. Curr Treat Options Cardiovasc Med 5:147–161PubMedGoogle Scholar
  9. 9.
    Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Theroux P (1981) Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 304:763–766PubMedCrossRefGoogle Scholar
  10. 10.
    Boin F, Wigley FM (2005) Understanding, assessing and treating Raynaud’s phenomenon. Curr Opin Rheumatol 17:752–760PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  • Carsten Tschöpe
    • 1
  • Dirk Westermann
    • 1
  • Paul Steendijk
    • 3
  • Mario Kasner
    • 1
  • Martin Rudwaleit
    • 2
  • Peter L. Schwimmbeck
    • 1
  • Wolfgang C. Poller
    • 1
  • Heinz-Peter Schultheiss
    • 1
  1. 1.Charitè—University Medicine Berlin, Campus Benjamin FranklinDepartment of Cardiology and PneumologyBerlinGermany
  2. 2.Department of Gastroenterology and RheumatologyCharité—University Medicine Berlin, Campus Benjamin FranklinBerlinGermany
  3. 3.Department of CardiologyLeiden University Medical CenterThe Netherlands

Personalised recommendations